TapewireFind a company

person · Reporting owner

Davis Mark Steven

Disclosed activity across 2 companies

Tapewire entity
38551
SEC CIK
0002024613

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
MYRIAD GENETICS INCMYGN · Entity 5953DirectorJune 04, 2026June 05, 2026
Yext, Inc.YEXT · Entity 5265DirectorJune 10, 2026June 12, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

MYRIAD GENETICS INC

Report date June 04, 2026 · Filed June 05, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect106,665 Reported balance After 2026-06-04 transaction · row 1
1 source row

Row 1 · 2026-06-04 · Grant · Acquired 59,701 · Balance 106,665

F1: Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant.

Filing footnotes · ownership attribution and instrument terms

F1: Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant.

Yext, Inc.

Report date June 10, 2026 · Filed June 12, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect89,631 Reported balance After 2026-06-11 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-06-11 · Exercise / conversion · Acquired 27,131 · Balance 89,631

F1: Each restricted stock unit represents a contingent right to receive one share of Yext, Inc.'s (the "Company") common stock.

F2: Includes 20,834 shares of restricted stock, which vest on June 12, 2027, subject to Reporting Person's continued service to Company on such date.

Restricted Stock UnitSEC Table II · derivative / convertible securityDirect43,209 Reported balance After 2026-06-10 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-06-10 · Grant · Acquired 43,209 · Balance 43,209

F1: Each restricted stock unit represents a contingent right to receive one share of Yext, Inc.'s (the "Company") common stock.

F3: 100% of the shares subject to the award vest on June 10, 2027, subject to the Reporting Person's continued service to the Company on such date.

Restricted Stock UnitSEC Table II · derivative / convertible securityDirect0 Reported balance After 2026-06-11 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2026-06-11 · Exercise / conversion · Disposed 27,131 · Balance 0

F1: Each restricted stock unit represents a contingent right to receive one share of Yext, Inc.'s (the "Company") common stock.

F4: 100% of the shares subject to the award vested on June 11, 2026.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit represents a contingent right to receive one share of Yext, Inc.'s (the "Company") common stock.

F2: Includes 20,834 shares of restricted stock, which vest on June 12, 2027, subject to Reporting Person's continued service to Company on such date.

F3: 100% of the shares subject to the award vest on June 10, 2027, subject to the Reporting Person's continued service to the Company on such date.

F4: 100% of the shares subject to the award vested on June 11, 2026.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 11, 2026 Filed Jun 12, 2026 20:29 UTC Yext, Inc. YEXT · Entity 5265 Exercise / conversionRestricted Stock Unit · Derivative 27,131 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-042882 · wk-form4_1781296195.xml · derivative · entry 3

Davis Mark Steven · CIK 0002024613 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 27,131 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Yext, Inc.'s (the "Company") common stock.

F4 · derivative.exercise_date: 100% of the shares subject to the award vested on June 11, 2026.

F4 · derivative.expiration_date: 100% of the shares subject to the award vested on June 11, 2026.

Read SEC document
June 11, 2026 Filed Jun 12, 2026 20:29 UTC Yext, Inc. YEXT · Entity 5265 Exercise / conversionCommon Stock 27,131 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-042882 · wk-form4_1781296195.xml · nonDerivative · entry 1

Davis Mark Steven · CIK 0002024613 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,631

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Yext, Inc.'s (the "Company") common stock.

F2 · balance_after: Includes 20,834 shares of restricted stock, which vest on June 12, 2027, subject to Reporting Person's continued service to Company on such date.

Read SEC document
June 10, 2026 Filed Jun 12, 2026 20:29 UTC Yext, Inc. YEXT · Entity 5265 GrantRestricted Stock Unit · Derivative 43,209 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-042882 · wk-form4_1781296195.xml · derivative · entry 2

Davis Mark Steven · CIK 0002024613 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,209

Underlying: Common Stock · 43,209 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Yext, Inc.'s (the "Company") common stock.

F3 · derivative.exercise_date: 100% of the shares subject to the award vest on June 10, 2027, subject to the Reporting Person's continued service to the Company on such date.

F3 · derivative.expiration_date: 100% of the shares subject to the award vest on June 10, 2027, subject to the Reporting Person's continued service to the Company on such date.

Read SEC document
June 04, 2026 Filed Jun 5, 2026 20:25 UTC MYRIAD GENETICS INC MYGN · Entity 5953 GrantCommon Stock 59,701 $0.00 $0.00
Disclosure

SEC source: 0002024613-26-000002 · wk-form4_1780691117.xml · nonDerivative · entry 1

Davis Mark Steven · CIK 0002024613 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,665

F1 · shares: Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant.

Read SEC document
June 11, 2025 Filed Jun 12, 2025 22:42 UTC Yext, Inc. YEXT · Entity 5265 GrantRestricted Stock Unit · Derivative 27,131 $0.00 $0.00
Disclosure

SEC source: 0001614178-25-000085 · wk-form4_1749768141.xml · derivative · entry 1

Davis Mark Steven · CIK 0002024613 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,131

Underlying: Common Stock · 27,131 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Yext, Inc.'s common stock.

F2 · derivative.exercise_date: 100% of the shares subject to the award vest on June 11, 2026, subject to the Reporting Person's continued service to the Issuer on such date.

F2 · derivative.expiration_date: 100% of the shares subject to the award vest on June 11, 2026, subject to the Reporting Person's continued service to the Issuer on such date.

Read SEC document
June 05, 2025 Filed Jun 6, 2025 20:05 UTC MYRIAD GENETICS INC MYGN · Entity 5953 GrantCommon Stock 24,148 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-029977 · wk-form4_1749240308.xml · nonDerivative · entry 1

Davis Mark Steven · CIK 0002024613 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,964

F1 · shares: Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant.

Read SEC document
December 10, 2024 Filed Dec 11, 2024 21:36 UTC MYRIAD GENETICS INC MYGN · Entity 5953 GrantCommon Stock 22,816 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-050787 · wk-form4_1733953005.xml · nonDerivative · entry 1

Davis Mark Steven · CIK 0002024613 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,816

F1 · shares: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant.

Read SEC document
June 12, 2024 Filed Jun 14, 2024 01:18 UTC Yext, Inc. YEXT · Entity 5265 GrantCommon Stock 62,500 $0.00 $0.00
Disclosure

SEC source: 0001614178-24-000077 · wk-form4_1718327913.xml · nonDerivative · entry 1

Davis Mark Steven · CIK 0002024613 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,500

F1 · shares: One-third of the shares subject to award shall vest on June 12, 2025, and then annually thereafter on each June 12, subject to the Reporting Person's continued service to the Company on such date until the award is fully vested on June 12, 2027.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.